Figure S8 from Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy
Résumé fourni par la source
Supplementary Figure 8: Comparison of survival outcomes in each cohort using different ctDNA stratification strategies—either based on ctFE detectability (undetectable: ctFE ≤0.0009, detectable: ctFE >0.0009; Methods) or high and low ctFE based on pre-treatment PFS (low: ctFE ≤0.016411, high: ctFE >0.016411; Methods). Hazard ratios from univariate Cox regression analysis for detectable vs. undetectable ctFE and for high vs. low ctFE are shown as squares; horizontal bars denote 95% CIs. CI, confidence interval; ctDNA, circulating tumor DNA; ctFE, circulating tumor fraction estimate; HR, hazard ratio; LA-RW, locally-advanced real-world NSCLC validation cohort (n = 94); LA-WU, locally-advanced NSCLC Washington University cohort (n = 24 pre-treatment, n = 26 mid-treatment); OM-RW, oligometastatic real-world NSCLC cohort (n = 309); OS, overall survival; PFS, progression-free survival.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Figure S8 from Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy
- Date Crossref
- 17/07/2026
- Éditeur
- American Association for Cancer Research (AACR)
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.